Estimation of electromagnetically controlled ionizing radiation therapy effectiveness based on probabilistic modeling
Main Article Content
Abstract
Background: Various radiobiological models aim to estimate crucial tumor cell (TC)‑killing effects for radiotherapy and radiation risk assessment, each with unique applications. This paper presents a specific probabilistic model for predicting tumor control probability (TCP) and introduces a user‑friendly standalone simulation app tailored for this purpose.
Methods: A pragmatic probabilistic model is suggested for estimating TCP by incorporating a fractionated treatment approach. Within this model, ionizing radiation induces the formation of killed cells, sublethally damaged cells, and undamaged cells (UDC), the impact of which is contingent upon the radiosensitivity of cells. This triad of cell types can be influenced by radiation during subsequent fractions, providing a nuanced understanding of the treatment dynamics.
Results: AMATLAB app has been developed for a TCP simulator. This simulator employs probabilistic modeling to describe radiation biological effects in a tumor subjected to homogeneous irradiation with a specified dose per fraction in a fractionated treatment. The key input parameters for the simulation include a cell radiosensitivity of 1.2, radiosensitivity of cell sub‑lethal damage at 3, TC volume of 1 cm3, TC density of 0.1 × 107, 30 virtual simulations, and 40 fractional radiation doses. Postsimulation, the resulting TCP is determined to be 86.7%.
Conclusion: The study’s simulator is a crucial tool for modeling radiation‑induced biological effects in fractionated irradiation of tumors. Its use of probabilistic foundations generates hypotheses and assesses the efficacy of fractionated radiation therapy, holding promise for enhancing the safety and effectiveness of cancer treatment.
Downloads
Article Details
Section

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
References
1. International Agency for Research on Cancer (IARC) Working Group on the Evaluation of Carcinogenic Risks to Humans. Non-Ionizing Radiation, Part 2: Radiofrequency Electromagnetic Fields. Vol. 102. Lyon, France: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans/World Health Organization, International Agency for Research on Cancer; 2013. p. 1.
2. Ahlbom A, Green A, Kheifets L, Savitz D, Swerdlow A, ICNIRP (International Commission for Non‑Ionizing Radiation Protection) Standing Committee on Epidemiology. Epidemiology of health effects of radiofrequency exposure. Environ Health Perspect 2004;112:1741‑54.
3. International Commission on Non‑Ionizing Radiation Protection (ICNIRP). Guidelines for limiting exposure to time‑varying electric and magnetic fields (1 Hz to 100 kHz). Health Phys 2010;99:818‑36.
4. Schüz J, Mann S. A discussion of potential exposure metrics for use in epidemiological studies on human exposure to radiowaves from mobile phone base stations. J Expo Anal Environ Epidemiol 2000;10:600‑5.
5. SCENIHR. Scientific Committee on Emerging and Newly Identified Health Risks: Potential Health Effects of Exposure to Electromagnetic Fields (EMF); 2015. Available from: https://ec.europa.eu/health/scientific_committees/emerging/docs/scenihr_o_041.pdfExit Disclaimer. [Last accessed on 2015 Aug 15].
6. Peyman A, Khalid M, Calderon C, Addison D, Mee T, Maslanyj M,et al. Assessment of exposure to electromagnetic fields from wireless computer networks (wi‑fi) in schools; results of laboratory measurements. Health Phys 2011;100:594‑612.
7. AGNIR. Health Effects from Radiofrequency Electromagnetic Fields. Report from the Independent Advisory Group on Non‑Ionising Radiation. In: Documents of the Health Protection Agency R, Chemical and Environmental Hazards. RCE 20, Health Protection Agency, UK (Ed.); 2012.
8. Zamanian A, Hardiman C. Electromagnetic radiation and human health: A review of sources and effects. High Freq Electron 2005;4:16‑26.
9. Interphone Study Group. Brain tumour risk in relation to mobile telephone use: Results of the INTERPHONE international case‑control study. Int J Epidemiol 2010;39:675‑94.
10. Kai OZ, Mansor NH. A study on the electromagnetic radiation in human head tissues on 5g mobile exposure. In: Ismail A, Dahalan WM, Öchsner A, editors. Advanced Materials and Engineering Technologies. Advanced Structured Materials. Vol. 162. Cham: Springer; 2022.
11. Chen X, Yue NJ, Chen W, Saw CB, Heron DE, Stefanik D, et al. A dose verification method using a monitor unit matrix for dynamic IMRT on Varian linear accelerators. Phys Med Biol 2005;50:5641‑52.
12. Liu H, Chang JY. Proton therapy in clinical practice. Chin J Cancer 2011;30:315‑26.
13. Klein EE. Electron-beam therapy: Dosimetry, planning, and techniques. In: Halperin EC, Perez CA, Brady LW, editors. Perez and Brady’s Principles and Practice of Radiation Oncology. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.
14. Mubarok S, Wahyu WE, Supriyanto PA. 2D dose reconstruction of IMRT patient‑specific QA based on log file. Radiat Phys Chem 2020;166:108473.
15. De Los Santos J, Popple R, Agazaryan N, Bayouth JE, Bissonnette JP, Bucci MK, et al. Image guided radiation therapy (IGRT) technologies for radiation therapy localization and delivery. Int J Radiat Oncol Biol Phys 2013;87:33‑45.
16. Sterzing F, Engenhart‑Cabillic R, Flentje M, Debus J. Image‑guided radiotherapy: A new dimension in radiation oncology. Dtsch Arztebl Int 2011;108:274‑80.
17. Chitapanarux I, Nobnop W, Onchan W, Klunklin P, Nanna T, Sitathanee C, et al. Hypofractionated whole breast irradiation with simultaneous integrated boost in breast cancer using helical tomotherapy with or without regional nodal irradiation: A report of acute toxicities. Front Oncol 2023;13:1122093. [doi: 10.3389/fonc.2023.1122093].
18. Phurailatpam R, Wadasadawala T, Chauhan K, Panda S, Sarin R. Dosimetric comparison of volumetric‑modulated arc therapy and helical tomotherapy for adjuvant treatment of bilateral breast cancer. J Radiother Pract 2022;21:36‑44.
19. Mantziaris G, Pikis S, Xu Z, Mullen R, Alzate J, Bernstein K, et al.Stereotactic radiosurgery for intraventricular metastases: A multicenter study. Neurosurgery 2023;92:565‑73.
20. Frakes JM, Figura NB, Ahmed KA, Juan TH, Patel N, Latifi K, et al.Potential role for LINAC‑based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases. J Neurosurg 2015;123:1261‑7.
21. Gutkin PM, Gore E, Charlson J, Neilson JC, Johnstone C, King DM,et al. Stereotactic body radiotherapy for metastatic sarcoma to the lung: Adding to the arsenal of local therapy. Radiat Oncol 2023;18:42.
22. Teixeira MS, Batista DV, Braz D, da Rosa LA. Monte Carlo simulation of novalis classic 6 MV accelerator using phase space generation in GATE/Geant4 code. Prog Nucl Energy 2019;110:142‑7.
23. Feinendegen LE. 1989 Douglas lea memorial lecture. The cell dose concept; potential application in radiation protection. Phys Med Biol 1990;35:597‑612.
24. International Commission on Radiation Units and Measurements (ICRU). Options for characterizing energy deposition. J ICRU 2011;11:1-40.
25. Monteiro C, Miarka L, Perea‑García M, Priego N, García‑Gómez P, Álvaro‑Espinosa L, et al. Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism. Nat Med 2022;28:752‑65.
26. Zhao L, Wu D, Mi D, Sun Y. Radiosensitivity and relative biological effectiveness based on a generalized target model. J Radiat Res 2017;58:8‑16.
27. Brenner DJ. The linear‑quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin Radiat Oncol 2008;18:234‑9.
28. Wada M, Suzuki M, Liu C, Kaneko Y, Fukuda S, Ando K, et al.Modeling the biological response of normal human cells, including
repair processes, to fractionated carbon beam irradiation. J Radiat Res 2013;54:798‑807.
29. Park C, Papiez L, Zhang S, Story M, Timmerman RD. Universal survival curve and single fraction equivalent dose: Useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys 2008;70:847‑52.
30. Nahum AE, Uzan J. (Radio) biological optimization of external‑beam radiotherapy. Comput Math Methods Med 2012;2012:329214.